On June 30th the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 ZYN nicotine pouch products following extensive scientific review, allowing Philip Morris International U.S.(PMI U.S) to market these products in the United States of America (USA) with a specific modified risk claim. A U.S FDA’s MRTP order […] The post U.S. FDA authorizes 20 ZYN nicotine pouches to be marketed with specific modified risk claim in US appeared first on MM News .



